Related Experiment Video
Updated: Dec 24, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Manel B Hammouda1, Amy E Ford1, Yuan Liu1
1Department of Dermatology, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
The c-Jun N-terminal kinases (JNKs), with its members JNK1, JNK2, and JNK3, is a subfamily of (MAPK) mitogen-activated protein kinases. JNK signaling regulates a wide range of cellular processes, including cell proliferation, differentiation, survival, apoptosis, and inflammation. Dysregulation of JNK pathway is associated with a wide range of immune disorders and cancer. Our objective is to provide a review of JNK proteins and their upstream regulators and downstream effector molecules in common skin disorders, including psoriasis, dermal fibrosis, scleroderma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma.
Insights
This review explores c-Jun N-terminal kinases (JNKs) and their role in skin conditions like psoriasis and skin cancers. Understanding JNK pathways is key for immune disorders and cancer research.
Area of Science:
- Molecular Biology
- Dermatology
- Immunology
Background:
- c-Jun N-terminal kinases (JNKs), a subfamily of mitogen-activated protein kinases (MAPK), regulate critical cellular functions.
- JNK signaling pathways are implicated in cell proliferation, differentiation, survival, apoptosis, and inflammation.
- Aberrant JNK pathway activity is linked to various immune disorders and cancers.
Purpose of the Study:
- To review the roles of JNK proteins (JNK1, JNK2, JNK3) in common skin disorders.
- To examine upstream regulators and downstream effectors of JNK signaling in dermatological conditions.
- To consolidate current knowledge on JNK involvement in psoriasis, dermal fibrosis, scleroderma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma.
Main Methods:
- Literature review of JNK signaling in skin biology and disease.
- Analysis of studies focusing on JNK pathway components in specific dermatological conditions.
- Synthesis of information on JNK regulators and effectors relevant to skin disorders.
Main Results:
- JNK pathway dysregulation is a common feature in inflammatory skin diseases like psoriasis and fibrotic conditions such as scleroderma.
- JNK signaling plays a significant role in the pathogenesis of skin cancers, including BCC, SCC, and melanoma.
- Specific upstream activators and downstream targets of JNK have been identified in various skin pathologies.
Conclusions:
- JNK proteins are crucial mediators in the development and progression of numerous skin disorders.
- Targeting the JNK pathway presents a potential therapeutic strategy for treating inflammatory and oncogenic skin conditions.
- Further research into JNK signaling mechanisms can uncover novel diagnostic and therapeutic targets for dermatological diseases.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
